Question 1

How many shares of TBIO does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC own?

Accepted Answer

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of TBIO (Telesis Bio, Inc.) before exiting the position in 2021-Q3.

Question 2

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's TBIO position worth?

Accepted Answer

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's TBIO position was last reported at $0 in 2021-Q3 before the exit.

Question 3

Is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC buying or selling TBIO?

Accepted Answer

In 2021-Q3, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC exited their TBIO position entirely (-100.0% change in shares).

Question 4

When did UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first buy TBIO?

Accepted Answer

Based on available 13F filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first reported a position in TBIO in 2020-Q2. They have held the position across 6 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$201.78	0
2021-Q2	Increased	38,029	+12.2%	$1M	0.0%	$359.82	28
2021-Q1	Decreased	33,910	-24.6%	$559,176	0.0%	—	0
2020-Q4	Increased	45,000	+19.4%	$829,350	0.0%	—	29
2020-Q3	Increased	37,700	+101.6%	$513,097	0.0%	—	39
2020-Q2	New	18,700	-	$335,104	0.0%	—	33

TBIO6 quarters

TBIO
6 quarters